Home/Filings/4/0000929638-23-001688
4//SEC Filing

Urso David M 4

Accession 0000929638-23-001688

CIK 0001262104other

Filed

Jun 5, 8:00 PM ET

Accepted

Jun 6, 4:37 PM ET

Size

5.2 KB

Accession

0000929638-23-001688

Insider Transaction Report

Form 4
Period: 2023-06-02
Urso David M
Sr. V.P. and General Counsel
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-02+166,571166,571 total
    Exercise: $7.50Exp: 2033-06-02Common Stock (166,571 underlying)
Footnotes (1)
  • [F1]One quarter of such options shall vest on June 2, 2024, and the remaining three quarters of such options shall vest monthly over a three year period beginning on June 2, 2024.

Documents

1 file

Issuer

MEI Pharma, Inc.

CIK 0001262104

Entity typeother

Related Parties

1
  • filerCIK 0001604256

Filing Metadata

Form type
4
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 4:37 PM ET
Size
5.2 KB